BIOCHEMICAL AND CELLULAR EFFECTS OF DIDEMNINS-A AND DIDEMNINS-B
- 1 January 1984
- journal article
- research article
- Vol. 44 (5) , 1796-1801
Abstract
Didemins are a new class of cyclic depsipeptides in which didemnin A is the major component, didemnin B the minor component and a trace of didemnin C is present. Didemnin B was more potent than was didemnin A against [mouse] B16 melanoma and P388 leukemia in vivo, and B was also .apprx. 20 times more cytotoxic than was didemnin A in vitro. Didemnin B was studied in greater detail for its biochemical and cellular effects. Didemnin B inhibited the in vitro growth of B16 > [mouse leukemia] L1210 > [Chinese hamster lung] N-79 cells = human foreskin fibroblast = [rat brain tumor] 9L > Chinese hamster ovary cells. Didemnin B was more lethal to exponentially growing B16 cells (50% lethal dose for a 2-h exosure, 17.5 ng/ml) than to plateau-phase cells (50% lethal dose for a 2-h exposure, 100 ng/ml). After a 24-h exposure, the 50% lethal dose for exponential- and plateau-phase B16 cells was 8.8 and 59.6 ng/ml, respectively. Chinese hamster ovary cells were not killed even at 25,000 ng/ml. Mitotic cells were the least sensitive to didemnin B, and cells became more sensitive as they progressed into G1 and S phase. Since cells in all phases were killed, didemnin B cannot be considered a phase-specific agent. Didemnin B inhibited the synthesis of protein than that of DNA, with much less inhibition of RNA synthesis. Cell progression studies showed that high doses (300 ng/ml for 2 h or 100 ng/ml for 24 h) of didemin B froze the cells in their respective phases with complete inhibition of cell progression or growth. At low doses (10 ng/ml for 2 h or 3 ng/ml for 24 h), the cells were blocked at the G1-S border thereby increasing the percentage of G1 cells and decreasing the percentage of S-phase cells. Cells continued to progress from S phase to G2 + M and from G2 + M to G1. The cytotoxicity to different cell lines and inhibition of macromolecule synthesis by didemnin A is also reported.This publication has 10 references indexed in Scilit:
- CELL-CYCLE EFFECTS OF CC-10651983
- SELECTIVE PROTECTION BY ANGUIDINE OF NORMAL VERSUS TRANSFORMED-CELLS AGAINST 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ADRIAMYCIN1983
- CC-1065 (NSC-298223), A MOST POTENT ANTI-TUMOR AGENT - KINETICS OF INHIBITION OF GROWTH, DNA-SYNTHESIS, AND CELL-SURVIVAL1982
- Didemnins: Antiviral and Antitumor Depsipeptides from a Caribbean TunicateScience, 1981
- REDUCTION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE AND ADRIAMYCIN CYTO-TOXICITY FOLLOWING CELL-CYCLE ARREST BY ANGUIDINE1981
- CELL KILL KINETICS OF SEVERAL NOGALAMYCIN ANALOGS AND ADRIAMYCIN FOR CHINESE-HAMSTER OVARY, L1210-LEUKEMIA, AND B-16-MELANOMA CELLS IN CULTURE1981
- EFFECT OF 7-CON-O-METHYLNOGAROL ON DNA-SYNTHESIS, SURVIVAL, AND CELL-CYCLE PROGRESSION OF CHINESE-HAMSTER OVARY CELLS1981
- Cycle-Dependent Anticancer Drug Cytotoxicity in Mammalian Cells Synchronized by Centrifugal Elutriation2JNCI Journal of the National Cancer Institute, 1980
- LETHAL AND CYTOKINETIC EFFECTS OF ANGUIDINE ON A HUMAN COLON CANCER CELL LINE1978
- PUROMYCIN-INDUCED NECROSIS OF CRYPT CELLS OF THE SMALL INTESTINE OF MOUSEThe Journal of cell biology, 1966